Consider drug interactions when prescribing warfarin and DOACs esp CYP3A4 and or p glycoprotein inhibitors or inducers May require altered dosing

By rray, 26 January, 2024
Detail (Long)
Consider drug interactions when prescribing warfarin and DOACs, esp. CYP3A4 and/or p-glycoprotein inhibitors or inducers. May require altered dosing.